The European Society for Medical Oncology (ESMO) shared a post on LinkedIn:
“AI and digital innovation are redefining cancer care, from clinical trials to patient monitoring.
Are you ready to explore what’s next?
Join us at ESMO25 for plenty forward-thinking sessions:
- AI-based image biomarkers in oncology, radiology, and pathology – Gain insights into AI in cancer image analysis, its current use in pathology and radiology, and its convergence for precision oncology.
- Clinical trials in the age of AI – Learn about AI-based procedures to augment trials, precision medicine beyond genomic tests, digital infrastructure, and AI-driven drug discovery
- Digital tools for off-site care – Evidence supporting remote monitoring, implementation of digital tools, and next steps in their development.
- ChatGPT and cancer care – Understand large language models in oncology, lessons from implementation, their role in drug development, and agentic AI. ELCAP (ESMO guidance on the use of Large Language Models in Clinical Practice) unveiled!
17–19 October.”
You can also read Glenda Ramos Martínez Receives the First ESMO Oncologist of the Year Award at ESMO25
